Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

State of our campuses: UFS extends vacation as from 28 September until 7 October 2016
2016-09-28

In solidarity with the call for free education for the poor and missing middle, a discussion was held with the University Management Committee this morning, in consultation with the student leadership, and after careful assessment of operational matters on all three campuses of the University of the Free State (UFS), we agreed upon the following:
 
1.    All classes, tests, and assignments will be suspended until Friday 7 October 2016. This means that the university will close on Wednesday 28 September 2016 for an extended vacation until 7 October 2016. The academic programme will resume on Monday 10 October 2016.
                     
2.    This will allow the entire university time to demonstrate solidarity, in collaboration with student leadership, academic and support staff, and the broader community in support of free higher education for the poor and missing middle.
                  
3.    The administration of the university will continue on Thursday 29
September 2016, and staff will have access to their offices to plan the additional academic support for students, to consider the re-scheduling of the academic calendar, to engage with the Department of Higher Education and Training in relation to the students’ demands, and to continue with support services during the extended vacation.
 
4.    The university management and student leadership will also, over the next three days, engage in discussions to provide for a platform that is conducive to continued collaboration between students and the university leadership.
 
5.    The suspension of tests, classes, and assignments will also allow time for a social compact and code of ethics for protests to be agreed upon and signed between student leadership and the university management.

 In respect of the Qwaqwa Campus, some protesting students yesterday intimidated others and forcibly removed staff, as well as security personnel. Today, university property was burnt. In view of our commitment to the safety of staff, students, and university property at the campus, it was necessary to evacuate the campus – including residences – with immediate effect. However, residential students are allowed to remain on campus until midday tomorrow (28 September 2016).

The university leadership again wants to emphasise its support for a national policy of free education for the poor and missing middle and stresses its support for peaceful protests on matters that are of concern to our students.
 
We further understand the frustration of many students and their parents/guardians at the closure of the campuses and the impact it has on academic staff, staff in the Support Services, our security personnel, teaching, learning, projects, assignments, lectures, tests, fieldwork, and the academic calendar in general, and commit to do all in our power to ensure the delivery of quality education to all our students under difficult circumstances.


Released by:
Lacea Loader (Director: Communication and Brand Management)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept